Keay Nakae


Chardan Reiterates Buy on Aralez Pharmaceuticals Inc (ARLZ) Following Acquisition of U.S. Rights for Toprol-XL

In a research note published Tuesday, Chardan analyst Keay Nakae reiterated a Buy rating on shares of Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) with a price target …

Chardan Slashes Price Target for Novavax, Inc. (NVAX); Offers Commentary on Recent Phase 3 Trial Failure

Chardan Capital analyst Keay Nakae is out today with a research note on shares of Novavax, Inc. (NASDAQ:NVAX), reiterating a Neutral rating, while slashing the price …

Chardan Reiterates Buy on Aralez Pharmaceuticals Inc (ARLZ) Following FDA Approval

In a research report released Friday, Chardan Capital analyst Keay Nakae reiterated a Buy rating on shares of Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) with a …

Chardan Capital Maintains Buy on StemCells Inc (STEM) Following Positive Interim Cervical Spine Data

In a research report issued today, Chardan Capital analyst Keay Nakae reiterated a Buy rating on shares of StemCells Inc (NASDAQ:STEM), with a price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts